Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide

Endocrinology

Volumn 145, Issue 10, 2004, Pages 4592-4602

  Strle, Klemen ^a   Broussard, Suzanne R ^a   McCusker, Robert H ^a   Shen, Wen Hong ^a   Johnson, Rodney W ^a   Freund, Gregory G ^a   Dantzer, Robert ^b   Kelley, Keith W ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CNRS   (France)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE DERIVATIVE; CYTOKINE; FUMONISIN B1; GLUTATHIONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MYOD PROTEIN; MYOGENIN; SOMATOMEDIN C; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOPRECIPITATION; INFLAMMATION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

ANIMALS; CELL LINE; CERAMIDES; CYTOKINES; DRUG SYNERGISM; HUMANS; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOBLASTS; MYOD PROTEIN; MYOGENIN; PHOSPHOPROTEINS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 4644221064     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1749     Document Type: Article

References (68)

1. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162
2. Kelley KW 2004 From hormones to immunity: the physiology of immunology. Brain Behav Immun 18:95-113
3. Ellis KJ, Lee PD, Pivarnik JM, Bukar JG, Gesundheit N 1996 Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone. J Clin Endocrinol Metab 81:3033-3038
4. Lee PD, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, Skolnik PR, Nerad JL, Kudsk KA, Jackson L, Ellis KJ, Gesundheit N 1996 A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 81:2968-2975
5. Chang HR, Dulloo AG, Bistrian BR 1998 Role of cytokines in AIDS wasting. Nutrition 14:853-863
6. Baracos VE 2000 Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition 16:1015-1018
7. Grounds MD 2002 Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 3:19-24
8. Carter CS, Pahor M, Sonntag WE 2001 Assessment of physical function in aging rodents: a strategy for improving preclinical testing. Exp Aging Res 27:271-282
9. Frost RA, Lang CH, Gelato MC 1997 Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138:4153-4159
10. Broussard SR, Zhou JH, Venters HD, Bluthé RM, Freund GG, Johnson RW, Dantzer R, Kelley KW 2001 At the interface of environment-immune interactions: cytokine and growth factor receptors. J Anim Sci 79:E268-E284
11. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614
12. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336
13. Broussard SR, McCusker RH, Novakofski JE, Strle K, Shen WH, Johnson RW, Freund GG, Dantzer R, Kelley KW 2003 Cytokine-hormone interactions: tumor necrosis factor α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 144:2988-2996
14. Broussard SR, McCusker RH, Novakofski JE, Strle K, Shen WH, Johnson RW, Dantzer R, Kelley KW 2004 IL-1β impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. J Immunol 172:7713-7720
15. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F 2003 The formation of skeletal muscle: from somite to limb. J Anat 202:59-68
16. Rudnicki MA, Jaenisch R1995 The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17:203-209
17. Shen WH, Zhou JH, Broussard SR, Freund GG, Dantzer R, Kelley KW 2002 Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res 62:4746-4756
18. Shen WH, Yin Y, Broussard SR, McCusker RH, Freund GG, Dantzer R, Kelley KW 2004 Tumor necrosis factor α inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem 279:7438-7446
19. Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP 2004 Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55:257-267
20. Cutler RG, Mattson MP 2001 Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev 122:895-908
21. Schmitz-Peiffer C 2000 Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12:583-594
22. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M 1992 TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776
23. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M 1994 Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015
24. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Kronke M 1996 FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937-947
25. Dbaibo GS, El-Assaad W, Krikorian A, Liu B, Diab K, Idriss NZ, El-Sabban M, Driscoll TA, Perry DK, Hannun YA 2001 Ceramide generation by two distinct pathways in tumor necrosis factor α-induced cell death. FEBS Lett 503:7-12
26. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, Choi DW, Hsu CY 1998 Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273: 16521-16526
27. Mathias S, Younes A, Kan CC, Orlow I, Joseph C, Kolesnick RN 1993 Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259:519-522
28. Rybakina EG, Nalivaeva NN, Pivanovich YU, Shanin SN, Kozinets A, Korneva EA 2001 The role of neutral sphingomyelinase in interleukin-1β signal transduction in mouse cerebral cortex cells. Neurosci Behav Physiol 31:439-444
29. Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, Shigenaga JK, Grunfeld C, Feingold KR 1998 Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol 18:1257-1265
30. Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, Downes CP, Hundal HS 2001 Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44:173-183
31. Schmitz-Peiffer C, Craig DL, Biden TJ 1999 Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274:24202-24210
32. Strle K, Zhou JH, Broussard SR, Venters HD, Johnson RW, Freund GG, Dantzer R, Kelley KW 2002 IL-10 promotes survival of microglia without activating Akt. J Neuroimmunol 122:9-19
33. Davaille J, Li L, Mallat A, Lotersztajn S 2002 Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 277:37323-37330
34. Hinkovska-Galcheva V, Boxer L, Mansfield PJ, Schreiber AD, Shayman JA 2003 Enhanced phagocytosis through inhibition of de novo ceramide synthesis. J Biol Chem 278:974-982
35. 2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 277:42943-42952
36. Porn-Ares MI, Chow SC, Slotte JP, Orrenius S 1997 Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609. Exp Cell Res 235:48-54
37. Sortino MA, Condorelli F, Vancheri C, Canonico PL 1999 Tumor necrosis factor-α induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways. Endocrinology 140:4841-4849
38. Ito J, Nagayasu Y, Ueno S, Yokoyama S 2002 Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner. J Biol Chem 277:44709-44714
39. Wang E, Norred WP, Bacon CW, Riley RT, Merrill Jr AH 1991 Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 266:14486-14490
40. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, Hannun YA 1998 Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-α-induced cell death. J Biol Chem 273:11313-11320
41. Liu B, Hannun YA 1997 Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272:16281-16287
42. Vandenburgh HH, Hatfaludy S, Karlisch P, Shansky J 1991 Mechanically induced alterations in cultured skeletal muscle growth. J Biomech 24(Suppl 1):91-99
43. SAS 2003 User's guide. Version 8.2. Cary, NC: SAS Institute
44. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM 1996 Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022
45. Kanety H, Hemi R, Papa MZ, Karasik A1996 Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 271:9895-9897
46. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA 2003 A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303
47. Bourbon NA, Sandirasegarane L, Kester M 2002 Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ: implications for growth arrest. J Biol Chem 277:3286-3292
48. Arenz C, Thutewohl M, Block O, Waldmann H, Altenbach HJ, Giannis A 2001 Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem 2:141-143
49. Layne MD, Farmer SR 1999 Tumor necrosis factor-α and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Exp Cell Res 249:177-187
50. Schutze S, Machleidt T, Kronke M 1994 The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukoc Biol 56:533-541
51. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor 1 stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116
52. Florini JR, Ewton DZ, Roof SL 1991 Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol 5:718-724
53. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W 1997 Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 272:27730-27736
54. Wong ML, Xie B, Beatini N, Phu P, Marathe S, Johns A, Gold PW, Hirsch E, Williams KJ, Licinio J, Tabas I 2000 Acute systemic inflammation upregulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 97:8681-8686
55. Lee JT, Xu J, Lee JM, Ku G, Han X Yang DI, Chen S, Hsu CY 2004 Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123-131
56. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM 2002 Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 283:C714-C721
57. Hayter HL, Pettus BJ, Ito F, Obeid LM, Hannun YA 2001 TNFα-induced glutathione depletion lies downstream of cPLA(2) in L929 cells. FEBS Lett 507:151-156
58. Ochiai T, Soeda S, Ohno S, Tanaka H, Shoyama Y, Shimeno H 2004 Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis. Neurochem Int 44:321-330
59. Baron P, Galimberti D, Meda L, Prat E, Scarpini E, Conti G, Moggio M, Prelle A, Scarlato G 2000 Synergistic effect of β-amyloid protein and interferon γ on nitric oxide production by C2C12 muscle cells. Brain 123(Pt 2):374-379
60. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N 2001 Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200
61. Fernandez AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI, Le Roith D 2001 Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15:1926-1934
62. Cheng ZQ, Adi S, Wu NY, Hsiao D, Woo EJ, Filvaroff EH, Gustafson TA, Rosenthal SM 2000 Functional inactivation of the IGF-1 receptor delays differentiation of skeletal muscle cells. J Endocrinol 167:175-182
63. Araki E, Lipes MA, Patti ME, Bruning JC, Haag 3rd B, Johnson RS, Kahn CR 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190
64. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furata Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S 1994 Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186
65. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF 1999 Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat Genet 23:32-40
66. Meadows KA, Holly JM, Stewart CE 2000 Tumor necrosis factor-α- induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol 183:330-337
67. Langen RC, Van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM 2004 Tumor necrosis factor-́ inhibits myogenic differentiation through MyoD protein destabilisation. FASEB J 18:227-237
68. Wilson EM, Hsieh MM, Rotwein P 2003 Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 278:41109-41113